Literature DB >> 3947693

Plasma melatonin--an index of brain aging in humans?

N P Nair, N Hariharasubramanian, C Pilapil, I Isaac, J X Thavundayil.   

Abstract

We investigated the age-related changes in the circadian rhythm of plasma melatonin as a potential index of brain aging in man. The subjects were 5 young men aged 19-25 years, 11 older men aged 51-65 years, 6 elderly men aged 66-89 years, 7 young women aged 19-25 years, 5 premenopausal women aged 45-50 years, 8 postmenopausal women aged 51-65 years, and 5 elderly women aged 66-75 years. They were all physically and psychiatrically normal. Serial blood samples were drawn from 8:00 AM until 8:00 AM on the next day, with the indoor illumination set at 300 Lux from 7:00 AM until 4:00 PM and at 50 Lux thereafter. Plasma melatonin was estimated by radioimmunoassay. The results show that there is a significant negative correlation between age and 24-hr secretion of plasma melatonin (r = -0.952, p less than 0.0001), between age and peak levels of plasma melatonin (r = -0.937, p less than 0.00001), and between age and the lag in time from sunset to the onset of significant elevation of plasma melatonin over daytime values (r = 0.916, p less than 0.0001). It is concluded that study of the circadian rhythm of plasma melatonin may prove to be a useful index of the aging process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947693     DOI: 10.1016/0006-3223(86)90141-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  11 in total

1.  Age, alcoholism and depression are associated with low levels of urinary melatonin.

Authors:  L Wetterberg; B Aperia; D A Gorelick; H E Gwirtzman; M T McGuire; E A Serafetinides; A Yuwiler
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

2.  Seasonal pattern of melatonin excretion in humans: relationship to daylength variation rate and geomagnetic field fluctuations.

Authors:  T J Paparrigopoulos; C N Stefanis
Journal:  Experientia       Date:  1996-03-15

Review 3.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Potential of melatonin replacement therapy in older patients with sleep disorders.

Authors:  I Haimov; P Lavie
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

5.  Estimation of time of death by quantification of melatonin in corpses.

Authors:  H Mikami; K Terazawa; T Takatori; S Tokudome; T Tsukamoto; K Haga
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

6.  The human pineal gland in aging and Alzheimer's disease: patterns of cytoskeletal antigen immunoreactivity.

Authors:  C A Pardo; L J Martin; J C Troncoso; D L Price
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Implications for affective disorders.

Authors:  M Steiner; G M Brown; S Goldman
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

8.  Aging and oxygen toxicity: Relation to changes in melatonin.

Authors:  R J Reiter
Journal:  Age (Omaha)       Date:  1997-10

Review 9.  Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.

Authors:  Masaomi Miyamoto
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

10.  The effects of aging on sleep parameters in a healthy, melatonin-competent mouse model.

Authors:  Jiffin K Paulose; Chanung Wang; Bruce F O'Hara; Vincent M Cassone
Journal:  Nat Sci Sleep       Date:  2019-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.